• 掃描立即下載
    掃描立即下載

EXEL Exelixis

45.44
0.21
(+0.46%)

Exelixis EXEL 非檢測生技產品

45.44
0.21
(+0.46%)
showMore
單位：美金千元
科目 2025/Q3 2025/Q2 2025/Q1 2024/Q4 2024/Q3 2024/Q2 2024/Q1 2023/Q4 2023/Q3 2023/Q2 2023/Q1 2022/Q4 2022/Q3 2022/Q2 2022/Q1 2021/Q4 2021/Q3 2021/Q2 2021/Q1 2020/Q4
營業收入淨額
597,755 568,261 555,447 566,755 539,542 637,178 425,226 479,652 471,920 469,848 408,788 423,917 411,738 419,427 355,980 451,140 328,423 385,177 270,230 270,052
營業成本
18,574 19,470 19,172 19,965 17,328 17,667 21,256 21,753 18,774 17,705 14,315 15,920 15,305 13,481 13,203 12,917 11,874 14,884 13,198 9,037
營業毛利
579,181 548,791 536,275 546,790 522,214 619,511 403,970 457,899 453,146 452,143 394,473 407,997 396,433 405,946 342,777 438,223 316,549 370,293 257,032 261,015
營業費用
342,641 335,215 - - - - - 376,111 470,729 374,293 365,643 456,075 313,820 322,240 259,534 321,579 264,928 247,285 261,639 236,718
研發費用
199,164 200,356 212,233 249,002 222,570 211,147 227,689 244,670 332,585 232,570 234,246 336,824 198,837 199,481 156,671 222,268 163,370 148,790 159,288 154,279
推銷及管理費用
123,661 134,859 137,183 134,328 111,801 132,015 113,984 131,441 138,144 141,723 131,397 119,251 114,983 122,759 102,863 99,311 101,558 98,495 102,351 82,439
非經常性項目費用
19,816 - - 254 51,768 475 32,835 - - - - - - - - - - - - -
其他營業費用
- - - - - - - - - - - - - - - - - - - -
營業利益
236,540 213,576 186,859 163,206 136,075 275,874 29,462 81,788 -17,583 77,850 28,830 -48,078 82,613 83,706 83,243 116,644 51,621 123,008 -4,607 24,297
其他收入及費用
15,873 16,839 18,831 21,567 18,680 16,971 19,805 21,251 23,401 22,536 19,448 16,651 9,429 4,802 1,986 1,377 1,639 1,880 2,592 3,830
利息費用
- - - - - - - - - - - - - - - - - - - -
稅前純益
252,413 230,415 205,690 184,773 154,755 292,845 49,267 103,039 5,818 100,386 48,278 -31,427 92,042 88,508 85,229 118,021 53,260 124,888 -2,015 28,127
所得稅
58,835 45,567 46,074 44,912 36,782 66,729 11,950 17,521 4,777 19,208 8,250 -1,254 18,832 17,836 16,656 22,855 15,056 28,796 -3,616 -261
稅後純益
193,578 184,848 159,616 139,861 117,973 226,116 37,317 85,518 1,041 81,178 40,028 -30,173 73,210 70,672 68,573 95,166 38,204 96,092 1,601 28,388
基本每股稅後盈餘(元)
0.72 0.68 0.57 0.49 0.41 0.78 0.12 0.28 0 0.25 0.12 -0.09 0.23 0.22 0.21 0.3 0.12 0.31 0.01 0.09
稀釋每股稅後盈餘(元)
0.7 0.65 0.55 0.48 0.4 0.76 0.12 0.27 0.01 0.25 0.12 -0.09 0.22 0.22 0.21 0.3 0.12 0.3 0 0.09
基本平均股數(千股)
268,421 272,583 278,804 284,525 285,622 289,216 300,757 308,482 315,496 324,205 324,420 323,256 322,148 321,117 319,582 317,567 315,380 314,117 312,473 310,774
稀釋平均股數(千股)
278,535 284,393 288,177 293,546 291,478 293,974 305,530 313,023 319,247 327,305 326,279 323,256 325,066 324,904 323,289 323,187 322,022 322,941 321,287 319,519
還原基本每股稅後盈餘(元)
0.72 0.68 0.57 0.49 0.41 0.78 0.12 0.28 0 0.25 0.12 -0.09 0.23 0.22 0.21 0.3 0.12 0.31 0.01 0.09
還原稀釋每股稅後盈餘(元)
0.7 0.65 0.55 0.48 0.4 0.76 0.12 0.27 0.01 0.25 0.12 -0.09 0.22 0.22 0.21 0.3 0.12 0.3 0 0.09
還原基本平均股數(千股)
268,421 272,583 278,804 284,525 285,622 289,216 300,757 308,482 315,496 324,205 324,420 323,256 322,148 321,117 319,582 317,567 315,380 314,117 312,473 310,774
還原稀釋平均股數(千股)
278,535 284,393 288,177 293,546 291,478 293,974 305,530 313,023 319,247 327,305 326,279 323,256 325,066 324,904 323,289 323,187 322,022 322,941 321,287 319,519
EBITDA(千元)
259,835 237,757 213,035 192,415 162,209 300,174 55,645 109,565 12,114 106,426 55,133 -25,481 97,705 93,284 89,719 119,952 58,064 128,556 1,212 30,537

目前沒有任何討論